A detailed history of Susquehanna International Group, LLP transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 85,818 shares of PYXS stock, worth $145,032. This represents 0.0% of its overall portfolio holdings.

Number of Shares
85,818
Previous 115,695 25.82%
Holding current value
$145,032
Previous $382,000 17.8%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.83 - $3.94 $84,551 - $117,715
-29,877 Reduced 25.82%
85,818 $314,000
Q2 2024

Aug 15, 2024

BUY
$3.06 - $5.58 $141,506 - $258,041
46,244 Added 66.59%
115,695 $382,000
Q1 2024

May 07, 2024

BUY
$2.03 - $6.59 $116,984 - $379,768
57,628 Added 487.42%
69,451 $295,000
Q4 2023

Feb 14, 2024

SELL
$1.4 - $2.09 $29,021 - $43,325
-20,730 Reduced 63.68%
11,823 $21,000
Q3 2023

Nov 14, 2023

SELL
$1.6 - $2.78 $17,683 - $30,724
-11,052 Reduced 25.35%
32,553 $64,000
Q2 2023

Aug 11, 2023

BUY
$2.46 - $4.07 $107,268 - $177,472
43,605 New
43,605 $111,000
Q2 2022

Aug 15, 2022

BUY
$2.02 - $4.53 $29,221 - $65,530
14,466 New
14,466 $34,000

Others Institutions Holding PYXS

About Pyxis Oncology, Inc.


  • Ticker PYXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,096,400
  • Market Cap $59.3M
  • Description
  • Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...
More about PYXS
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.